Veterinary Stereotactic Radiosurgery System Market Size & Growth Forecast 2027–2036, By Segments (End Use, Product), Regional Demand Trends (North America, Asia Pacific, Europe), Key Country Insights (U.S., Japan, South Korea, Germany, France, Italy), and Competitive Landscape
Market Size and Growth Outlook
Veterinary Stereotactic Radiosurgery System Market size stood at USD 3.9 billion in 2026 and is predicted to grow at a 9.6% CAGR from 2027 to 2036, reaching USD 9.75 billion by 2036. The industry revenue for 2027 is assessed at USD 4.22 billion.
Get more details on this report
Request Free Sample ReportVeterinary Stereotactic Radiosurgery System Market Intelligence Snapshot
Regional Market Dynamics
- North America led the market in 2026 due to its established specialty veterinary hospitals, advanced oncology infrastructure, and broader adoption of precision radiosurgery for complex cancer treatments.
- Asia Pacific is forecast to expand at an 11.54% CAGR, supported by veterinary care modernization, stronger diagnostic capabilities, and increasing demand for specialized oncology treatments for companion animals.
Segment Momentum
- Academic & Research Institutions accounted for 60.81% of the market in 2026, supported by advanced oncology infrastructure, specialist expertise, and established workflows for complex, high-precision radiation treatments.
- Proton Beam Radiation Therapy (PBRT)/Flash-RT is the fastest-growing product segment as providers and research institutions increasingly explore advanced radiation technologies for complex veterinary oncology applications.
Market Expansion Drivers
- Rising pet cancer treatment adoption increasing demand for non-invasive stereotactic radiosurgery systems.
- AI-enabled radiotherapy and real-time tumor tracking improving precision veterinary oncology outcomes.
- Expanding investments in advanced veterinary specialty hospitals supporting radiosurgery technology deployment.
Leading Market Participants
- Key players in the veterinary stereotactic radiosurgery system market include Elekta AB (Sweden), Accuray Incorporated (United States), Varian Medical Systems, Inc. (United States), IBA Radiopharma Solutions (Belgium), Xstrahl Ltd. (United Kingdom), Panacea Medical Technologies Pvt. Ltd. (India), ViewRay, Inc. (United States), Brainlab AG (Germany), RaySearch Laboratories AB (Sweden), Alcen SAS (France).
Global Market Forecast Snapshot
Market Outlook
- 2026 Market Size: USD 3.9 billion
- 2027 Estimated Market Size: USD 4.22 billion.
- Projected Market Size: USD 9.75 billion by 2036
- Growth Forecast: 9.6% CAGR (2027-2036)
Regional and Segment Outlook
- Leading Regional Market: North America
- High-Growth Regional Hub: Asia Pacific
- Core Revenue Segment: Academic & Research Institutions (End Use) | LINAC (Product)
- Emerging Opportunity Segment: Hospitals & Clinics (End Use) | Proton Beam Radiation Therapy (PBRT)/ Flash-RT (Product)
Market Growth Drivers and Industry Trends
Rising pet cancer treatment adoption increasing demand for non-invasive stereotactic radiosurgery systems
Increasing awareness of veterinary oncology and the availability of advanced cancer treatment options are encouraging pet owners to pursue specialized therapies for companion animals diagnosed with tumors. The veterinary stereotactic radiosurgery system market is gaining from the preference for highly targeted treatment approaches that can address tumors while limiting exposure of surrounding healthy tissue. Stereotactic radiosurgery can deliver concentrated radiation to selected tumor sites without requiring conventional invasive surgery in appropriate cases, making it an attractive option for certain veterinary oncology applications. Greater willingness to pursue sophisticated treatments for companion animals is also encouraging veterinary specialists to expand their cancer care capabilities and incorporate advanced radiation-based procedures.
AI-enabled radiotherapy and real-time tumor tracking improving precision veterinary oncology outcomes
The incorporation of artificial intelligence, image guidance, and real-time tumor tracking is enhancing the precision with which radiation treatment can be planned and delivered in veterinary oncology. These technologies are supporting the veterinary stereotactic radiosurgery system market by enabling clinicians to better identify tumor boundaries, account for movement, and optimize radiation delivery around sensitive anatomical structures. AI-assisted treatment planning can help analyze imaging information and support more consistent positioning and dose planning, while tracking technologies can improve the management of motion during treatment. Such capabilities are particularly relevant for complex veterinary cases where treatment accuracy and protection of surrounding tissues are important clinical considerations.
Expanding investments in advanced veterinary specialty hospitals supporting radiosurgery technology deployment
Investment in specialized veterinary healthcare infrastructure is increasing the availability of sophisticated diagnostic and treatment services for companion animals. As specialty hospitals expand their oncology, imaging, and radiation therapy capabilities, the veterinary stereotactic radiosurgery system market is benefiting from greater institutional capacity to adopt advanced radiosurgery equipment. Specialty facilities can provide the clinical expertise, imaging infrastructure, treatment planning resources, and trained personnel required to operate complex radiation systems effectively. The development of comprehensive veterinary centers is also enabling greater integration between cancer diagnosis, treatment planning, radiation delivery, and post-treatment monitoring within specialized care settings.
| Growth Driver | Impact on CAGR | Regulatory Influence | Geographic Relevance | Adoption Rate | Impact Timeline |
|---|---|---|---|---|---|
| Rising pet cancer treatment adoption increasing demand for non-invasive stereotactic radiosurgery systems | 1.90% | High | North America, Europe | High | Near Term |
| AI-enabled radiotherapy and real-time tumor tracking improving precision veterinary oncology outcomes | 1.70% | Moderate | North America, Asia Pacific | High | Mid Term |
| Expanding investments in advanced veterinary specialty hospitals supporting radiosurgery technology deployment | 1.40% | Moderate | Europe, Asia Pacific | Emerging | Mid Term |
Unlock insights tailored to your business with our bespoke market research solutions.
Click to get your customized report now.
Regional Demand Dynamics
North America (Largest Region)
The veterinary stereotactic radiosurgery system market was led by North America in 2026, benefiting from advanced veterinary healthcare infrastructure, high adoption of specialized oncology services, and increasing demand for precision treatment options for companion animals. Veterinary hospitals and specialty centers in the region increasingly have access to sophisticated diagnostic imaging and radiation therapy capabilities, creating favorable conditions for adoption of stereotactic radiosurgery systems. Rising pet healthcare expenditure and growing willingness among owners to pursue advanced treatment for complex conditions are also supporting demand. Improvements in veterinary oncology expertise and the broader adoption of precision-focused treatment approaches further strengthen the region's market position.
Asia Pacific (Fastest-Growing Region)
Asia Pacific is the fastest-growing region, supported by expanding veterinary infrastructure, rising companion animal ownership, and increasing awareness of advanced veterinary treatment options. Urbanization and changing attitudes toward pet healthcare are encouraging greater spending on specialized diagnostics and therapeutic services. Veterinary hospitals are progressively adopting advanced imaging and radiation-based technologies as clinical capabilities improve, particularly in markets with expanding specialty care networks. Growing professional awareness of veterinary oncology and increasing investment in modern animal healthcare facilities are expected to broaden access to stereotactic radiosurgery and support regional market development.
| Parameter | North America | Asia Pacific | Europe | Latin America | MEA |
|---|---|---|---|---|---|
| Innovation Hub i Scale Nascent Developing Advanced | |||||
| Cost-Sensitive Region i Scale Low Medium High | |||||
| Regulatory Environment i Scale Restrictive Neutral Supportive | |||||
| Demand Drivers i Scale Weak Moderate Strong | |||||
| Development Stage i Scale Emerging Developing Developed | |||||
| Adoption Rate i Scale Low Medium High | |||||
| New Entrants / Startups i Scale Sparse Moderate Dense | |||||
| Macro Indicators i Scale Weak Stable Strong |
Key Country Insights
Germany 🇩🇪
Precision Veterinary CareGermany is expanding access to advanced veterinary oncology through specialized treatment centers equipped with stereotactic radiosurgery systems. Veterinary providers in Germany prioritize treatment accuracy, clinical outcomes, and collaboration with diagnostic imaging specialists.
France 🇫🇷
Clinical Treatment PrecisionFrance is adopting veterinary stereotactic radiosurgery systems within referral hospitals focused on advanced oncology care. Veterinary professionals in France emphasize accurate treatment delivery, multidisciplinary case management, and improved therapeutic outcomes for companion animals.
Italy 🇮🇹
Referral Center DevelopmentItaly is expanding specialized veterinary oncology capabilities through investments in advanced radiosurgery equipment. Referral centers in Italy are enhancing precision cancer treatment services while strengthening collaboration between imaging, surgery, and radiation therapy specialists.
Japan 🇯🇵
Specialty Clinic ExpansionJapan is increasing the adoption of advanced radiation technologies within companion animal specialty practices. Veterinary hospitals in Japan focus on minimally invasive treatment solutions supported by sophisticated imaging and precision treatment planning capabilities.
South Korea 🇰🇷
Companion Cancer SolutionsSouth Korea is strengthening veterinary oncology services as demand for advanced companion animal healthcare grows. Specialty clinics in South Korea are integrating stereotactic radiosurgery with advanced diagnostic imaging to deliver targeted treatment for complex tumor cases.
United States 🇺🇸
Advanced Oncology AdoptionThe U.S. veterinary stereotactic radiosurgery system market is supported by growing availability of advanced specialty veterinary hospitals. Clinics in the U.S. continue investing in precision radiation technologies that improve treatment options for complex companion animal cancers while expanding referral services.
Segment Leadership and Growth Trends
Veterinary Stereotactic Radiosurgery System Market Share (%), by End Use, 2026
Go beyond the chart, access full insights & data tables
Request Free Sample ReportEnd Use Segment Analysis: Academic & Research Institutions (Largest Segment) vs Hospitals & Clinics (Fastest-Growing Segment)
Academic & research institutions accounted for the largest share of the veterinary stereotactic radiosurgery system market, reaching 60.81% in 2026, supported by their role in advancing veterinary oncology research, evaluating emerging treatment approaches, and developing specialized radiation therapy protocols. These institutions provide environments for clinical research and technology validation, while growing attention to precision treatment for complex animal tumors is reinforcing demand for sophisticated stereotactic radiosurgery capabilities.
Hospitals & clinics represent the fastest-growing end-use segment as veterinary care increasingly incorporates advanced oncology treatments that were traditionally associated with human medicine. Greater availability of specialized veterinary services, rising emphasis on noninvasive tumor management, and improvements in radiation delivery and treatment planning are encouraging clinical adoption of stereotactic radiosurgery systems.
Product Segment Analysis: LINAC (Largest Segment) vs Proton Beam Radiation Therapy (PBRT)/ Flash-RT (Fastest-Growing Segment)
LINAC systems held the largest position in the veterinary stereotactic radiosurgery system market, accounting for 55.76% in 2026, owing to their established use in delivering precisely targeted radiation and their compatibility with sophisticated treatment-planning workflows. Their versatility, established clinical infrastructure, and ability to support multiple radiation treatment approaches make LINAC systems an important platform for veterinary oncology centers seeking advanced treatment capabilities.
Proton beam radiation therapy (PBRT)/ flash-RT is advancing at the fastest pace as interest grows in highly precise radiation delivery approaches that can limit exposure to surrounding healthy tissue. Continued development of advanced dose-delivery techniques and growing interest in minimizing treatment-related effects are encouraging research and adoption of next-generation radiation technologies for complex veterinary oncology applications.
| Segment | Sub-Segment | Largest Segment | Fastest Growing |
|---|---|---|---|
| End Use | Hospitals & Clinics, Academic & Research Institutions | Academic & Research Institutions | Hospitals & Clinics |
| Product | Gamma Knife, LINAC, Proton Beam Radiation Therapy (PBRT)/ Flash-RT, CyberKnife | LINAC | Proton Beam Radiation Therapy (PBRT)/ Flash-RT |
Competitive Landscape and Market Positioning
Top players in the veterinary stereotactic radiosurgery system market:
1. Elekta AB (Sweden)
2. Accuray Incorporated (United States)
3. Varian Medical Systems Inc. (United States)
4. IBA Radiopharma Solutions (Belgium)
5. Xstrahl Ltd. (United Kingdom)
6. Panacea Medical Technologies Pvt. Ltd. (India)
7. ViewRay Inc. (United States)
8. Brainlab AG (Germany)
9. RaySearch Laboratories AB (Sweden)
10. Alcen SAS (France)
Advancements in veterinary oncology are driving technological progress in the veterinary stereotactic radiosurgery system market. Ongoing research is supporting the development of highly precise treatment platforms integrated with advanced imaging capabilities, enabling improved treatment planning and expanding the adoption of minimally invasive cancer therapies in veterinary practice.
| Company | Market Share | Company Revenue | Revenue CAGR (%) | Product Portfolio | Geographic Presence | Innovation / R&D Focus | Strategic Developments |
|---|---|---|---|---|---|---|---|
| Elekta AB (Sweden) | |||||||
| Accuray Incorporated (United States) | |||||||
| Varian Medical Systems Inc. (United States) | |||||||
| IBA Radiopharma Solutions (Belgium) | |||||||
| Xstrahl Ltd. (United Kingdom) | |||||||
| Panacea Medical Technologies Pvt. Ltd. (India) | |||||||
| ViewRay Inc. (United States) | |||||||
| Brainlab AG (Germany) | |||||||
| RaySearch Laboratories AB (Sweden) | |||||||
| Alcen SAS (France). |
Industry Development/News
| Company Name | Date | Key Development |
|---|---|---|
| LSU Vet Med | Sep-24 | LSU Vet Med acquired a specialized Varian Trilogy linear accelerator, integrating advanced stereotactic radiotherapy and IMRT capabilities with RapidArc technology into its veterinary oncology department. |
| Bristol Vet Specialists (BVS) | Jun-24 | Bristol Vet Specialists (BVS) unveiled a brand-new £13.5m state-of-the-art animal medical center featuring one of England's few pet-dedicated stereotactic linear accelerator setups. |
| Varian Medical Systems, Inc. | Feb-24 | Varian Medical Systems, Inc. secured 510(k) regulatory clearance from the U.S. FDA for its TrueBeam and Edge radiotherapy machinery integrated with the HyperSight medical imaging tool. |
| Thrive Pet Healthcare | Oct-23 | Thrive Pet Healthcare expanded its operational veterinary footprint to over 380 medical sites across 37 U.S. states by launching its Thrive Pet Healthcare Specialists hospital in Hoffman Estates. |
Customize Your Report
Explore examples of how this report can be tailored to different research needs, including custom segments, additional topics or chapters, and related reports. Click a section of the wheel or its numbered marker to explore the available options.
Veterinary Stereotactic Radiosurgery System Market — Custom Segments
| Segment | Sub-Segment |
|---|---|
| Animal Type | Canine, Feline, Equine, Other Companion & Veterinary Animals |
| Treatment Indication | Brain & Central Nervous System Tumors, Head & Neck Tumors, Spinal Tumors, Other Tumors |
| Service Model | In-House Treatment, Referral-Based Treatment, Mobile & Contract-Based Services |
Veterinary Stereotactic Radiosurgery System Market — Custom TOC
| Custom Chapter | Custom Details |
|---|---|
| Veterinary Oncology Treatment Adoption Assessment |
|
| Veterinary Technology Investment Landscape |
|
| Advanced Veterinary Care Facility Expansion Assessment |
|
Need a different cut of the data?
Request Custom ResearchHow big is the veterinary stereotactic radiosurgery system market?
How will the veterinary stereotactic radiosurgery system industry grow in terms of size and CAGR by 2036?
What factors are driving adoption of stereotactic radiosurgery in veterinary oncology?
How are specialty hospital investments supporting growth in the veterinary stereotactic radiosurgery system market?
Why do Academic & Research Institutions lead the veterinary stereotactic radiosurgery system market?
Which product segment is expanding fastest in the veterinary stereotactic radiosurgery system market?
Why is North America the largest veterinary stereotactic radiosurgery system market?
What is driving growth in the veterinary stereotactic radiosurgery system market in Asia Pacific?
Who are the major participants shaping the veterinary stereotactic radiosurgery system landscape?
Our Clients
"The team took the time to understand our specific business needs and delivered a report that was well aligned with our objectives. Their expertise and understanding of the industry were clearly reflected in the quality and relevance of the insights provided."
Siemens Healthcare
"Our experience in acquiring the research report has been excellent. The depth of analysis, and actionable insights provided have been extremely valuable in supporting our ongoing R&D efforts."
GC Biopharma
"The report offered a comprehensive view of the market trends. The in-depth segmentation and analysis of emerging opportunities gave us a better understanding of the market."
Medtronic
Our Research Team & Methodology
Every Fundamental Business Insights report is built by a dedicated vertical research team, validated through a structured primary-and-secondary methodology, and reviewed for accuracy before it reaches you.
Research Team Overview
Prepared by the Healthcare & Medical Devices Research Team
Delivery
Published
Demand
Available
Support
Trust & Compliance
Research Domains
10 coverage areasResearch Intelligence
| Source | Reference |
|---|---|
| World Health Organization (WHO) | www.who.int |
| U.S. Food & Drug Administration (FDA) | www.fda.gov |
| European Medicines Agency (EMA) | www.ema.europa.eu |
| Centers for Disease Control and Prevention (CDC) | www.cdc.gov |
| National Institutes of Health (NIH) | www.nih.gov |
| National Center for Biotechnology Information (NCBI) | www.ncbi.nlm.nih.gov |
| PubMed | pubmed.ncbi.nlm.nih.gov |
| ClinicalTrials.gov | clinicaltrials.gov |
| International Organization for Standardization (ISO) | www.iso.org |
| ASTM International | www.astm.org |
| Advanced Medical Technology Association (AdvaMed) | www.advamed.org |
| Medical Device Innovation Consortium (MDIC) | mdic.org |
| Biotechnology Innovation Organization (BIO) | www.bio.org |
| International Federation of Pharmaceutical Manufacturers & Associations (IFPMA) | www.ifpma.org |
| U.S. Pharmacopeia (USP) | www.usp.org |
| European Directorate for the Quality of Medicines & HealthCare (EDQM) | www.edqm.eu |
| World Organisation for Animal Health (WOAH) | www.woah.org |
| American Hospital Association (AHA) | www.aha.org |
| OECD Health | www.oecd.org/health |
| World Bank Data | data.worldbank.org |
Research Workflow & Quality Assurance
Data Collection
Verified information gathered through primary and secondary research.
Data Triangulation
Cross-validation using multiple independent data sources.
Forecast Modelling
Market estimates developed using historical trends and analytical models.
Analyst Validation
Findings reviewed by domain experts for accuracy and consistency.
Editorial & Quality Review
Final editorial, quality, and compliance checks before publication.
Final Publication
Released after successful completion of the internal review process.
Report Coverage
📊 Market Assessment
- Market Size & Forecast
- Market Segmentation
- Regional Analysis
- Growth Drivers & Challenges
- Market Dynamics
🏢 Competitive Intelligence
- Competitive Landscape
- Company Profiles
- Competitive Benchmarking
- Mergers & Acquisitions
- Market Share Analysis or Key Company Strategies
🔍 Strategic Analysis
- Value Chain Analysis
- Porter's Five Forces
- PESTLE Analysis
- Pricing Trends
- Supply-Demand Analysis
🚀 Future Outlook
- Technology Landscape
- Regulatory Landscape
- Investment & Funding Landscape
- Emerging Opportunities
- Future Market Outlook
Have a question about this report or need a custom scope?
Request Customization